(Q49180207)

English

Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity

scientific article published in August 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Hany M El-Bassossy

1

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

Shaymaa M Abo-Warda

2

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

Ahmed Fahmy

3

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

39

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

8

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

643-649

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

Role of microRNAs in diabetes and its cardiovascular complications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

The endothelium and vascular inflammation in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Managing hypertension in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Mechanisms by which Thiazolidinediones Enhance Insulin Action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Vascular effects of PPARgamma activators - from bench to bedside

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

A novel advanced glycation index and its association with diabetes and microangiopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Cinnamaldehyde protects from the hypertension associated with diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Beneficial effect of aqueous garlic extract on the vascular reactivity of streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Rosiglitazone increases extravasation of macromolecules and endothelial nitric oxide synthase in skeletal muscles of the fructose-fed rat model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Troglitazone inhibits long-term glycation and oxidation of low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2012.05724.X

21 January 2018

Identifiers

10.1111/J.1440-1681.2012.05724.X

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/22594672

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49180207&oldid=2223917417"